Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).

NCT03917199 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.

NCT NCT03917199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Lead sponsor
National Institute of Cardiology, Warsaw, Poland
Phase
Observational
Overall status
Completed
Start date
November 30, 2016
Completion date
July 11, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

computed tomography, coronary artery disease, myocardial perfusion imaging